Since 1987, asthma mortality rates have risen 40 , prompting the development of potent drug therapies and the improvement of knowledge and skills in the asthmatic. However, despite medical and nonmedical efforts, a significant decline in the development of adverse asthma events, including mortality rates, has not been observed, suggesting that alternate intervention methods must be considered and developed..